MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹818 Cr | ₹515 Cr | ₹435 Cr | ₹325 Cr | ₹308 Cr |
What is the latest Total Non-Current Assets ratio of MARKSANS PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹818 Cr |
Mar2023 | ₹515 Cr |
Mar2022 | ₹435 Cr |
Mar2021 | ₹325 Cr |
Mar2020 | ₹308 Cr |
How is Total Non-Current Assets of MARKSANS PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹818 Cr | 58.90 | |
Mar2023 | ₹515 Cr | 18.40 | |
Mar2022 | ₹435 Cr | 33.78 | |
Mar2021 | ₹325 Cr | 5.43 | |
Mar2020 | ₹308 Cr | - |
Compare Total Non-Current Assets of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,848.9 Cr | 5.2% | -18.5% | 64.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 5.2% |
-18.5% |
64.8% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses